Benchmark Reiterates Speculative Buy on HeartBeam, Maintains $8 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bill Sutherland has reiterated a Speculative Buy rating on HeartBeam (NASDAQ:BEAT) and maintained a price target of $8.
September 04, 2024 | 11:55 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Bill Sutherland has reiterated a Speculative Buy rating on HeartBeam, maintaining a price target of $8. This suggests confidence in the company's potential growth.
The reiteration of a Speculative Buy rating and maintenance of an $8 price target by a reputable analyst suggests positive sentiment and potential upside for HeartBeam's stock. This could lead to increased investor interest and a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100